4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-074926
Chief Executive Officer sold 2,562 shares at $1.63 ($4,176)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian Chief Executive Officer | 2022-06-27 | Sale | −2,562 | $1.63 | $4,176 | 3,290 | D |
| Open-market sales · 2,562 sh · avg $1.63 · $4,176 | |||||||
Loading xslF345X03/tm2219493-1_4seq1.xml…